Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-2980 |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3977 |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-5340 |
| Retevmoselpercatinib | Selpercatinib 160 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-5562 |
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6082 |
| Retevmoselpercatinib | Selpercatinib 120 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6120 |
| Revtorpykgedatolisib | Gedatolisib 180 mg/1 | Injection, Powder, For solutionIntravenous | Celcuity Inc. | 84577-751 |
| Rhapsidoremibrutinib | Remibrutinib 25 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-1483 |
| Rhopressanetarsudil | Netarsudil mesylate .2 mg/mL | Solution/ dropsOphthalmic, Topical | Alcon Laboratories, Inc. | 70727-497 |
| Rinvoqupadacitinib | Upadacitinib 45 mg/1 | Tablet, Extended releaseOral | AbbVie Inc. | 0074-1043 |
| Rinvoqupadacitinib | Upadacitinib 15 mg/1 | Tablet, Extended releaseOral | AbbVie Inc. | 0074-2306 |
| Rinvoqupadacitinib | Upadacitinib 30 mg/1 | Tablet, Extended releaseOral | AbbVie Inc. | 0074-2310 |
| Rinvoqupadacitinib | Upadacitinib 1 mg/mL | SolutionOral | AbbVie Inc. | 0074-2320 |
| Rocklatannetarsudil and latanoprost ophthalmic solution, 0.02%/0.005% | Netarsudil mesylate .2 mg/mL; Latanoprost .05 mg/mL | Solution/ dropsOphthalmic, Topical | Alcon Laboratories, Inc. | 70727-529 |
| Romvimzavimseltinib | Vimseltinib 14 mg/1 | CapsuleOral | Deciphera Pharmaceuticals, LLC | 73207-302 |
| Romvimzavimseltinib | Vimseltinib 20 mg/1 | CapsuleOral | Deciphera Pharmaceuticals, LLC | 73207-303 |
| Romvimzavimseltinib | Vimseltinib 30 mg/1 | CapsuleOral | Deciphera Pharmaceuticals, LLC | 73207-304 |
| Rydapt | Midostaurin 25 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-0698 |
| Sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-7248 |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | Rising Pharma Holdings, Inc. | 16571-806 |
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | NORTHSTAR RX LLC | 16714-187 |
| sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | NORTHSTAR RX LLC | 16714-188 |
| sirolimus | Sirolimus 2 mg/1 | Tablet, Film coatedOral | NORTHSTAR RX LLC | 16714-189 |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | Camber Pharmaceuticals, Inc. | 31722-316 |
| Sirolimus | Sirolimus 1 mg/1 | TabletOral | AvPAK | 50268-718 |